Phloridzin Reveals New Treatment Strategies for Liver Fibrosis

Area of Science:

• Hepatology
• Pharmacology
• Biochemistry

Background:

• Liver fibrosis is a significant health concern with limited effective treatments.
• Current therapies for liver fibrosis present challenges in clinical application.
• Phloridzin, a natural compound from lychee core, is explored for its therapeutic potential.

Purpose of the Study:

• To evaluate the efficacy of phloridzin in treating carbon tetrachloride (CCl4)-induced liver fibrosis in a mouse model.
• To elucidate the underlying molecular mechanisms of phloridzin's action in liver fibrosis.
• To investigate the impact of phloridzin on cellular processes like ferroptosis and metabolic pathways.

Main Methods:

• Induction of liver fibrosis using CCl4 in C57/BL6N mice.
• Administration of phloridzin to treated groups.
• Assessment of therapeutic effects via biochemical marker analysis and ultrasound detection.
• High-throughput mRNA and lncRNA sequencing for mechanistic insights.
• Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis.

Main Results:

• Phloridzin treatment significantly reduced collagen deposition in liver tissues.
• Key biochemical markers, including serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), laminin, and hyaluronic acid, were decreased.
• Pathway analysis indicated that phloridzin primarily influences cell ferroptosis.
• lncRNA analysis revealed associations with focal adhesions, intercellular adhesion, cell-substrate junctions, and carbon metabolism.

Conclusions:

• Phloridzin demonstrates significant therapeutic efficacy against liver fibrosis.
• The mechanism of action involves modulation of cell ferroptosis and carbon metabolism.
• Phloridzin may also impact biomechanical properties related to cell adhesion and extracellular matrix.
• Phloridzin represents a potential novel therapeutic agent for liver fibrosis.